Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Phaedra Tachtatzis MD
Associate Professor
Department of Medicine
Division of Gastroenterology

OFFICE ADDRESS:
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
09/1991 - 07/1992 Ten GCSEs, Sydenham High School for Girls, London, United Kingdom, London
09/1992 - 07/1994 Five A-levels, Rainham Mark Grammar School, Kent, United Kingdom, Kent
09/1994 - 07/1999 MB ChB, University of Aberdeen, Aberdeen, SC, United Kingdom, Scotland
08/2000 - 07/2002 MRCP, Membership of the Royal College of Physicians, London, United Kingdom, England
10/2007 - 2015 MD, University of Aberdeen, Aberdeen, United Kingdom, Cambridge

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
08/1999 - 08/2000 Pre-Registration House Officer, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
08/2000 - 08/2002 Senior House Officer, Oxford Deanery Medical Rotation, Oxford, United Kingdom
08/2002 - 01/2003 Senior House Officer, Intensive Care Medicine, Royal Victoria Infirmary, New Castle, United Kingdom
01/2003 - 11/2003 Locum Appointment for Training, Gastroenterology & GIM, Royal Berkshire & Battle Hospitals, Reading, United Kingdom
11/2003 - 09/2004 Specialist Registrar (NTN), Gastroenterology & GIM, Darlington Memorial Hospital, United Kingdom
09/2004 - 10/2005 Specialist Registrar (NTN), Freeman Hospital, New Castle, United Kingdom
10/2005 - 10/2006 Specialist Registrar (NTN), Gastroenterology & GIM, South Tyneside District Hospital, South Shields, United Kingdom
10/2006 - 10/2007 Specialist Registrar (NTN), Hepatology Fellow, Hepatology, Freeman Hospital, New Castle, United Kingdom
10/2007 - 04/2010 Specialist Registrar (NTN), Out of Programme Research: Hepatology Research Registrar, Hepatology, Addenbrooke’s Hospital, Cambridge, England
04/2010 - 12/2011 Specialist Registrar (NTN), Gastroenterology & GIM, University Hospital of North Durham, New Castle, United Kingdom
01/2012 - 09/2012 Hepatology Fellow, Hepatology, King’s College Hospital, London, England

FACULTY APPOINTMENTS:
09/2012 - 08/2023 Consultant Hepatologist, Leeds Teaching Hospitals NHS Trust, St James’s University Hospital, United Kingdom, Leeds
08/2023 - Present Associate Professor of Medicine, Medicine, Gastroenterology and Hepatology, Medical College of Wisconsin, 8701 W Watertown Plank Rd, Milwaukee, WI 53226

HOSPITAL STAFF PRIVILEGES:
09/2012 - 08/2023 Leeds Teaching Hospitals NHS Trust, St James’s University Hospital, United Kingdom, Leeds
08/2023 - Present Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Avenue, Milwaukee, WI 53226

SPECIALTY BOARDS AND CERTIFICATION:
Licensure
Number Issue DateExpiration
General Medicine Council
4602066
2009
None
    

AWARDS AND HONORS:
07/1994 University Entrance Bursary
07/1994 George Thomson Bursary
07/1995 Distinction in Genetics
07/1995 Distinction in Cell Biology
07/1995 Distinction in Physiology
07/1995 Distinction in Statistics
07/1995 Distinction in Biochemistry
07/1995 Distinction in Chemistry
07/1996 First Class Honours in Biochemistry
07/1996 Bursaries awarded for academic excellence
07/1996 First Class Honours in Physiology
07/1997 Distinction in Medical Microbiology
07/1997 Bursaries awarded for academic excellence
07/1998 Bursaries awarded for academic excellence
07/1999 Dr C E Anderson memorial fund award for elective project Distinction in Medicine
08/2000 Letter of commendation for overall performance as a first year SHO
03/2005 Travel award for AASLD awarded by BASL
03/2011 Young Investigator’s Bursary awarded by EASL

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
01/2001 - 01/2012 European Association for the Study of the Liver
07/2002 - Present Royal College of Physicians of London
01/2004 - Present British Society of Gastroenterology
01/2005 - Present British Association for the Study of the Liver

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Chronic Hepatitis B Infection and Telomeres, Digestive Disease Week, Chicago, United States, 03/2009
Alcoholic Liver Disease: EASL Monothematic Conference, Athens, Greece, 12/2010
Astellas Development Programme in Transplantation, Barcelona, Spain, 05/2012
Janssen-Sponsored Hepatitis C Workshop, Madrid, Spain, 04/2014
Waiting List Patient Monitoring and Optimization, Continuing Education Program, Leeds, England, 07/2021
Can Liver Biopsy Guide the Management of Deranged Liver Function Tests in Liver Transplant Recipients Receiving Kaftrio?, European Cystic Fibrosis Conference, Rotterdam, The Netherlands, 06/2022
 
National
Liver Course, King’s College Liver Course, London, England, 11/2002
Colonoscopy Course, James Cook University Hospital, Middlesbrough, England, 07/2004
Clinical Nutrition Day, New Castle, United Kingdom, 09/2004
Advances in Hepatitis C Management, London, England, 03/2005
Capsule Endoscopy Course, Durham. England, 05/2006
Cambridge Liver Symposium, Cambridge, England, 10/2008
Cambridge Liver Symposium, Cambridge, England, 10/2009
Management & Leadership Skills, London, England, 02/2010
Advanced Life Support, Papworth Hospital, Cambridge, England, 03/2010
CV and Interview Skills, New Castle, United Kingdom, 05/2010
Advanced Liver Transplantation Workshop, London, England, 01/2011
Masterclass in Chronic Hepatitis B&C, King’s College Hospital, London, England, 04/2011
HIV-HBV Co-Infection, North of England HBV meeting, Leeds, England, 11/2012
Masterclass in immunosuppression, Delivered Lecture on Post-Transplant HCV Recurrence, Leeds, England, 05/2013
Masterclass in Viral Hepatitis, Presented a Challenging Case, London, England, 05/2013
Speaker and Conference Organizer, Leeds Hepatology Course, Leeds, England, 11/2013
Presentation of Leeds Liver Unit experience of triple antiviral therapy for HCV and Q&A session as expert panel member, Hepatitis C in the UK: a real-world perspective, London, England, 11/2013
Speaker and contributor to national guidelines, BTS LDLT guidelines, London, England, 11/2013
Invited case presentation, UK & Eire Liver Transplant Meeting, Cambridge, England, 01/2014
Training the Trainers Course, Leeds, England, 05/2014
Talk on Resistance in Chronic Hepatitis B Infection, Birmingham, England, 05/2014
National Workshop on Graft Utilisation, BTS NHSBT Congress, 02/2021
 
Regional
Speaker and Conference Co-Organizer, Yorkshire & the Humber Liver Network Liver Transplant Symposium, Leeds, England, 12/2013
North of England Viral Hepatitis, Sheffield, England, 01/2014
Training the Trainers Course, Leeds, England, 05/2014
Regional Hepatitis C Symposium, Sheffield, England, 06/2014
Frailty and Wait List Management, Leeds Referrer’s Day, Leeds, England, 10/2019
Regional RCP Study Day, Leeds, England, 05/2020
Frailty and Wait List Management, Leeds Referrer’s Day, Leeds, England, 10/2021
 
Local
Metabolic Liver Disease, Annual AASLD Meeting Review, Milwaukee, WI, 02/10/2024
Chair: Debates and Dilemmas in the Management of Pre-Transplant Patients, Transplant Symposium, 04/13/2024
Strategies to Reduce Frailty & Optimize Nutrition in Liver Disease, Transplant Symposium, 04/05/2025
Strategies to Reduce Frailty & Optimize Nutrition in Liver Disease, Transplant Service Line Educational Lectures, 04/11/2025
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Newton JL, Hudson M, Tachtatzis PM, Sutcliffe K, Pairman J, Burt JA & Jones DE. Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. Hepatology. 2007 Jun;45(6):1496-505. PMID: 17538969
2. Tachtatzis PM, Brais R & Alexander G. An instance of hepatic steatosis in HBV infection. Viral Hepatitis in Practice. 2009;1(2)4-5.
3. Alfahad A, Thet EM, Radwan F, Sudhakar J, Nini K & Tachtatzis PM. Spontaneous Incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report. Journal of medical case reports. 2012;6(1):272. PMID: 22943389
4. Verma S, Tachtatzis PM, Penrhyn-Lowe S, Scarpini C, Jurk D, Von Zglinicki T, Coleman N & Alexander GJ. Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver. Hepatology. 2012 Oct;56(4):1510-20. PMID: 22504828
5. Davis M & Tachtatzis PM. From haemochromatosis to liver transplant. BMJ. 2013;347:f4423. PMID: 23963547
6. Aravinthan A, Scarpini C, Tachtatzis PM, Verma S, Penrhyn-Lowe S, Harvey R, Davies SE, Allison M, Coleman N & Alexander GJ. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. Journal of Hepatology. 2013 Mar;58(3):549-56. PMID: 23142622
7. Tachtatzis PM, Marshall A, Aravinthan A, Verma S, Penrhyn-Lowe S, Mela M, Scarpini C, Davies SE, Cole-man N, Alexander GJ. Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis. PLoS One. 2015. May 29;10(5): e0127511. PMID: 26024529
8. Tachtatzis PM, Marshall A, Aravinthan A, Verma S, Penrhyn-Lowe S, Mela M, Scarpini C, Davies SE, Coleman N, Alexander GJM. Correction: Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis. PLoS One. 2015 Jul 28;10(7):e0134315. doi: 10.1371/journal.pone.0134315. eCollection 2015. PMID: 26218071
9. Hill QA, Harrison LC, Padmakumar AD, Owen RG, Prasad KR, Lucas GF, Tachtatzis P. A fatal case of transplantation-mediated alloimmune thrombocytopenia following liver transplantation. Hematology. 2017. Apr;22(3):162-167. PMID: 27764999
10. Fararjeh FA, Mahmood S, Tachtatzis P, Yallop D, Devereux S, Patten P, Agarwal K, Suddle A, O'Grady J, Heaton N, Marcus R, Kassam S. A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation. Eur J Haematol. 2018. Jan;100(1):98-103. PMID: 29094407
11. Vionnet J, Miquel R, Abraldes JG, Wall J, Kodela E, Lozano J, Ruiz P, Navasa M, Marshall A, Nevens F, Gel-son, W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson KJ, Bonaccorsi-Riani E, Femg S, Bucuvalas J, Ferguson J, Quaglia A, Sidorova J, Elstad M, Douiri A, Sanchez-Fueyo A. Non-invasive alloimmune risk stratification of long-term liver transplant recipients. J Hepatol. 2021;75:1409-1419. PMID: 34437910
12. Tachtatzis P, Spoletini G, Clifton I, Etherington C, Peckham D. Changes in liver biochemistry and tacrolimus levels following the introduction of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and liver transplant. J Cyst Fibros. 2023 May 8:S1569-1993(23)00129-7. doi: 10.1016/j.jcf.2023.04.023. Online ahead of print. PMID: 37164896.
13. Vionnet J, Torres-Yaguana J, Miquel R, Abraldes JG, Wall J, Kodela E, Lozano JJ, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson KJ, Bonaccorsi-Riani E, Ferguson J, Quaglia A, Demetris AJ, Lesniak AJ, Elstad M, Delord M, Douiri A, Rebollo-Mesa I, Martinez-Llordella M, Silva JAF, Markmann JF, Sánchez-Fueyo A. Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression. Am J Transplant. 2025 May;25(5):1045-1058. doi: 10.1016/j.ajt.2024.12.002. Epub 2024 Dec 18. PMID: 39706366.
 
Abstracts
1. Vionnet J, Miquel R, Abraldes JG, Lozano JJ, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson K, Bonaccorsi-Riani E, Ferguson J, Quaglia A, Elstad M, Delord M, Douiri A, Sánchez-Fueyo A. The clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation: the LIFT prospective RCT. Southampton (UK): National Institute for Health and Care Research; 2025 Apr. PMID: 40238953.